EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Multiscale vascularized tumor-on-a-chip via bioprinting for drug research

Jing Liu, Ying Zhao, Bihan Ren, Dingming Li, Tianma He, Haizhongshi Zhang, Zhenlei Zhang, Haochen Liu

International Journal of Bioprinting · 2025-06-26 · 11 (4) · 378

DOI: 10.36922/ijb025180180 ↗
AbstractBibliografische Angaben

Abstract

Current in vitro tumor models often fail to recapitulate the hierarchical vascular architecture and dynamic interactions of the tumor microenvironment (TME), limiting their utility in cancer research. In this study, we present a multiscale vascularized tumor model integrating coaxial bioprinting, inkjet printing, and fused deposition modeling (FDM) to address this challenge. Firstly, coaxial bioprinting enabled the fabrication of dual-layered vasculature with an endothelium layer and a smooth muscle layer. Secondly, tumor spheroids with precise size control (±10 μm) were generated via inkjet printing by modulating Methacrylate Gelatin (GelMA) concentration and valve actuation time. An FDM-printed chip was designed to co-culture these components under perfusion, facilitating the self-organization of a microvascular network around tumor spheroids. After 11 days of dynamic culture, the model demonstrated tumor-driven angiogenic sprouting and early metastatic behavior, validated by the upregulation of metastasis-related genes (CD44, MMP2, N-cadherin) in vascularized cohorts. Drug testing with paclitaxel revealed dose-dependent suppression of tumor proliferation and invasion. This platform not only mimics the structural and functional complexity of the TME but also provides a scalable, physiologically relevant tool for investigating tumor–vascular crosstalk and evaluating anti-cancer therapeutics.  

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →